Page last updated: 2024-09-05

succinobucol and Disease Models, Animal

succinobucol has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bao, X; Cao, H; He, X; Li, Y; Yin, Q; Yu, H; Zhang, Z1
Cao, H; Dan, Z; He, X; Li, Y; Shen, Q; Xu, M; Xu, Y; Yin, Q; Yu, H; Zeng, L; Zhang, P; Zhang, Z; Zhong, D; Zou, L1
Alexander, RW; Butteiger, D; Chapman, A; Daugherty, A; Edwards, D; Hill, RR; Hoong, LK; Jones, M; Landers, LK; Medford, RM; Meng, CQ; Saxena, U; Somers, PK; Suen, KL; Sundell, CL; Wasserman, MA1
Doggrell, SA1
Tanimoto, T1

Reviews

2 review(s) available for succinobucol and Disease Models, Animal

ArticleYear
Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth.
    Expert opinion on investigational drugs, 2003, Volume: 12, Issue:11

    Topics: Animals; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Clinical Trials as Topic; Coronary Restenosis; Disease Models, Animal; Endothelium, Vascular; Humans; Probucol

2003
[Research and developmental strategy of anti-dyslipidemic agents].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2007, Volume: 129, Issue:4

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Apolipoprotein A-I; Carrier Proteins; Cholesterol Ester Transfer Proteins; Coronary Disease; Disease Models, Animal; Drug Design; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hyperlipidemias; Hypolipidemic Agents; Oligoribonucleotides, Antisense; Probucol; Receptors, G-Protein-Coupled; Receptors, Nicotinic

2007

Other Studies

3 other study(ies) available for succinobucol and Disease Models, Animal

ArticleYear
pH-Responsive Wormlike Micelles with Sequential Metastasis Targeting Inhibit Lung Metastasis of Breast Cancer.
    Advanced healthcare materials, 2016, Feb-18, Volume: 5, Issue:4

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Female; Hydrogen-Ion Concentration; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Neoplasm Metastasis; Polyethylene Glycols; Probucol; RAW 264.7 Cells; Vascular Cell Adhesion Molecule-1

2016
A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer.
    Theranostics, 2016, Volume: 6, Issue:3

    Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Cell Movement; Disease Models, Animal; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Lung Neoplasms; Mice, Inbred BALB C; Nanostructures; Neoplasm Invasiveness; Polyethylene Glycols; Probucol; Treatment Outcome

2016
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Disease Models, Animal; Endothelium, Vascular; Humans; Lipid Metabolism; Macaca fascicularis; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Probucol

2003